Page last updated: 2024-08-22

pyrvinium and ER-Negative PR-Negative HER2-Negative Breast Cancer

pyrvinium has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ambs, S; Auslander, N; Boe, A; Buglioni, S; Camera, E; Cardone, L; Ciliberto, G; Dattilo, R; De Maria, R; Doglioni, G; Ercolani, C; Fendt, SM; Grande, S; Iezzi, M; Lamolinara, A; Luciani, AM; Manni, I; Mottini, C; Muscolini, M; Planque, M; Ruppin, E; Tang, W; Trisciuoglio, D	1

Other Studies

1 other study(ies) available for pyrvinium and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism. Cancer research, 2020, 10-01, Volume: 80, Issue:19 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cholesterol; Drug Repositioning; Female; Glucose; Humans; Lipid Metabolism; Mice, Inbred NOD; Neoplastic Stem Cells; Pyrvinium Compounds; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2020

Article

Year

Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism.

Cancer research, 2020, 10-01, Volume: 80, Issue:19

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cholesterol; Drug Repositioning; Female; Glucose; Humans; Lipid Metabolism; Mice, Inbred NOD; Neoplastic Stem Cells; Pyrvinium Compounds; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2020